BIONET Corp. (TPEX:1784)
Taiwan · Delayed Price · Currency is TWD 79.50
-1.50 (-1.85%)
At close: Mar 27, 2026
BIONET Revenue
In the year 2025, BIONET had annual revenue of 1.24B TWD with 1.19% growth. BIONET had revenue of 343.44M in the quarter ending December 31, 2025, with 4.43% growth.
Revenue
1.24B
Revenue Growth
+1.19%
P/S Ratio
3.23
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.24B | 14.57M | 1.19% |
| Dec 31, 2024 | 1.22B | 94.73M | 8.40% |
| Dec 31, 2023 | 1.13B | 146.93M | 14.99% |
| Dec 31, 2022 | 980.38M | 58.96M | 6.40% |
| Dec 31, 2021 | 921.42M | 114.85M | 14.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals | 19.01B |
| PharmaEssentia | 15.63B |
| Orient EuroPharma | 4.60B |
| Sagittarius Life Science | 346.08M |
| Bonraybio | 306.31M |
| BioGend Therapeutics | 222.34M |
| Caliway Biopharmaceuticals | 38.04M |
| ACRO Biomedical | 36.50M |